Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04943575 · ClinicalTrials.gov registry record · NA
Study to Evaluate the Efficacy of EZC Pak in Adults With Upper Respiratory Infection (URI)
A NA study of Common Cold, sponsored by PPC Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 1
- Study location
NCT04943575: Completed NA study of Common Cold, sponsored by PPC Pharmaceuticals.
NCT04943575 is a NA study of Common Cold that has completed, run by PPC Pharmaceuticals. The registered enrollment target is 360 participants, roughly in line with the 362-participant average among 5 other Common Cold trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04943575, a NA study of Common Cold, has completed, sponsored by PPC Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized-controlled interventional clinical trial to evaluate the effectiveness of EZC Pak \& EZC Pak+D for the treatment of the common cold and/or a URI.
Primary Outcome
The primary objective of this study is to understand if EZC Pak (and EZC Pak +D) changes the severity and duration of an upper respiratory illness (URI) compared to a placebo. The study uses a scale of 1-4 (no symptoms to severe symptoms) to assess the effectiveness of the intervention.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT EZC Pak
- DIETARY_SUPPLEMENT EZC Pak +D
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-01-30 |
| Phase | NA |
What the finished NCT04943575 record still lists
NCT04943575 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 362-participant average among 5 other Common Cold trials with a reported enrollment target.
The record links to 1 condition, with Common Cold appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT04943575 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04943575 about?
NCT04943575 is a clinical study titled "Study to Evaluate the Efficacy of EZC Pak in Adults With Upper Respiratory Infection (URI)". A randomized-controlled interventional clinical trial to evaluate the effectiveness of EZC Pak \& EZC Pak+D for the treatment of the common cold and/or a URI.
What is the current status of trial NCT04943575?
This trial is currently completed. It is a NA study. The enrollment target is 360 participants. The study started on 2021-06-01. Estimated completion is 2022-01-30.
What conditions does trial NCT04943575 study?
This clinical trial studies the following conditions: Common Cold.
What interventions are being tested in trial NCT04943575?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), EZC Pak (DIETARY_SUPPLEMENT), EZC Pak +D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04943575?
This trial is sponsored by PPC Pharmaceuticals, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04943575 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Common Cold
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Throat Spray on the Incidence and Duration of Sickness
ACTIVE NOT RECRUITING · NA
-
A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin
COMPLETED · Phase 4
-
Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses
COMPLETED · Phase 2
-
Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo)
COMPLETED · Phase 3
-
Audio Data Collection for Identification and Classification of Coughing
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI